Skip to content

Clinical trials

Completed Phase 2 Cytokine Release Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytokine Release Syndrome Phase: Phase 2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20208
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthea Hospital Bari1
BioAegis Therapeutics Inc.1
Biocon Limited1
Hadassah Medical Organization1
Incyte Corporation1
Kinevant Sciences GmbH1
Lin Chen1
Maimónides Biomedical Research Institute of Córdoba1
Marcela V. Maus, M.D.,Ph.D.1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytokine Release Syndrome12
COVID-196
Lymphoma, Follicular2
Lymphoma, Non-Hodgkin2
Respiratory Distress Syndrome2
Severe Acute Respiratory Syndrome2
Autonomic Nervous System Diseases1
Coronavirus Infections1
Heart Failure1
Lung Injury1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.